Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Synaptic Systems (SySy) is a specialized biotechnology company based in Göttingen, Germany, focused on providing premium antibodies for the global neuroscience research community. Established in 1998 as a spin-off from the Max Planck Institute, the company has built a reputation for high-quality reagents targeting synaptic proteins and markers of the central nervous system. Their product portfolio includes a wide range of monoclonal and polyclonal antibodies, as well as recombinant antibodies, validated for applications like immunohistochemistry and western blotting. Beyond neuroscience, they offer tools for cell biology, histopathology, and RNA research. The company emphasizes rigorous in-house validation to ensure product specificity and reproducibility. Synaptic Systems serves academic institutions, research hospitals, and pharmaceutical companies worldwide.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Synaptic Systems.